-
1
-
-
72849156982
-
Studies on conditions associated with disturbed gamma globulin formation (gammopathies)
-
Waldenstrom J. Studies on conditions associated with disturbed gamma globulin formation (gammopathies). Harvey Lect. 1960;56:211-31.
-
(1960)
Harvey Lect
, vol.56
, pp. 211-231
-
-
Waldenstrom, J.1
-
2
-
-
0017813724
-
Monoclonal gammopathy of undetermined significance.Natural history in 241 cases
-
Kyle RA. Monoclonal gammopathy of undetermined significance. Natural history in 241 cases. Am J Med. 1978;64:814-26.
-
(1978)
Am J Med
, vol.64
, pp. 814-826
-
-
Kyle, R.A.1
-
3
-
-
77957964303
-
Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: Implications for recategorizing disease entities in the presence of evolving scientific evidence
-
Rajkumar SV, Kyle RA, Buadi FK. Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: implications for recategorizing disease entities in the presence of evolving scientific evidence. Mayo Clin Proc. 2010;85:945-8.
-
(2010)
Mayo Clin Proc
, vol.85
, pp. 945-948
-
-
Rajkumar, S.V.1
Kyle, R.A.2
Buadi, F.K.3
-
4
-
-
77957964303
-
Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: Implications for recategorizing disease entities in the presence of evolving scientific evidence
-
Rajkumar SV, Kyle RA, Buadi FK. Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: implications for recategorizing disease entities in the presence of evolving scientific evidence. Mayo Clin Proc. 2010;85:945-8.
-
(2010)
Mayo Clin Proc
, vol.85
, pp. 945-948
-
-
Rajkumar, S.V.1
Kyle, R.A.2
Buadi, F.K.3
-
5
-
-
0018848543
-
Smoldering multiple myeloma
-
Kyle RA, Greipp PR. Smoldering multiple myeloma. N Engl J Med. 1980;302:1347-9.
-
(1980)
N Engl J Med
, vol.302
, pp. 1347-1349
-
-
Kyle, R.A.1
Greipp, P.R.2
-
7
-
-
0027397466
-
Risk of disease progression in asymptomatic multiple myeloma
-
Dimopoulos MA, Moulopoulos A, Smith T, et al. Risk of disease progression in asymptomatic multiple myeloma. Am J Med. 1993;94:57-61.
-
(1993)
Am J Med
, vol.94
, pp. 57-61
-
-
Dimopoulos, M.A.1
Moulopoulos, A.2
Smith, T.3
-
8
-
-
0028235301
-
Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma
-
Witzig TE, Kyle RA, OFallon WM, Greipp PR. Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma. Br J Haematol. 1994;87:266-72.
-
(1994)
Br J Haematol
, vol.87
, pp. 266-272
-
-
Witzig, T.E.1
Kyle, R.A.2
Ofallon, W.M.3
Greipp, P.R.4
-
9
-
-
0038509089
-
Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders
-
a report of the International Myeloma Working Group
-
Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003;121:749-57.
-
(2003)
Br J Haematol
, vol.121
, pp. 749-757
-
-
-
10
-
-
77954610729
-
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
-
Kyle RA, Durie BG, Rajkumar SV, et al. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia. 2010;24:1121-7.
-
(2010)
Leukemia
, vol.24
, pp. 1121-1127
-
-
Kyle, R.A.1
Durie, B.G.2
Rajkumar, S.V.3
-
11
-
-
34250694807
-
Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma
-
Kyle RA, Remstein ED, Therneau TM, et al. Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. N Engl J Med. 2007;356:2582-90.
-
(2007)
N Engl J Med
, vol.356
, pp. 2582-2590
-
-
Kyle, R.A.1
Remstein, E.D.2
Therneau, T.M.3
-
12
-
-
23044481861
-
Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance
-
Rajkumar SV, Kyle RA, Therneau TM, et al. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood. 2005;106:812-7.
-
(2005)
Blood
, vol.106
, pp. 812-817
-
-
Rajkumar, S.V.1
Kyle, R.A.2
Therneau, T.M.3
-
13
-
-
38349136782
-
Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma
-
Dispenzieri A, Kyle RA, Katzmann JA, et al. Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma. Blood. 2008;111:785-9.
-
(2008)
Blood
, vol.111
, pp. 785-789
-
-
Dispenzieri, A.1
Kyle, R.A.2
Katzmann, J.A.3
-
14
-
-
34948907366
-
New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells
-
Perez-Persona E, Vidriales MB, Mateo G, et al. New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells. Blood. 2007;110:2586-92.
-
(2007)
Blood
, vol.110
, pp. 2586-2592
-
-
Perez-Persona, E.1
Vidriales, M.B.2
Mateo, G.3
-
15
-
-
78649726232
-
Multiple myeloma precursor disease
-
Landgren O, Waxman AJ. Multiple myeloma precursor disease. JAMA. 2010;304:2397-404.
-
(2010)
JAMA
, vol.304
, pp. 2397-2404
-
-
Landgren, O.1
Waxman, A.J.2
-
17
-
-
77957046247
-
Smoldering (asymptomatic) multiple myeloma: Revisiting the clinical dilemma and looking into the future
-
Waxman AJ, Kuehl WM, Balakumaran A, et al. Smoldering (asymptomatic) multiple myeloma: revisiting the clinical dilemma and looking into the future. Clin Lymphoma, Myeloma Leuk. 2010;10:248-57.
-
(2010)
Clin Lymphoma, Myeloma Leuk
, vol.10
, pp. 248-257
-
-
Waxman, A.J.1
Kuehl, W.M.2
Balakumaran, A.3
|